Breaking News, World News and Taiwan News.

AstraZeneca shares plunge 14% after snub to raised Pfizer bid

LONDON--The share price of British drugmaker AstraZeneca slumped on Monday after it rejected a final takeover bid from U.S. rival Pfizer worth US$117 billion.

The shares tumbled 13.99 percent to 41.49 pounds in early morning deals on London's FTSE 100 index of leading companies, which was down 0.49 percent at 6,822.25 points.

AstraZeneca on Monday rejected a final takeover bid from Pfizer that was pitched at 55 pounds per share, valuing the British firm at 69 billion pounds.

Pfizer had made an improved and final offer on Sunday, but warned that it would not proceed without a recommendation from AstraZeneca management.

Write a Comment
CAPTCHA Code Image
Type in image code
Change the code
 Receive China Post promos
 Respond to this email
WSJA
Subscribe  |   Advertise  |   RSS Feed  |   About Us  |   Career  |   Contact Us
Sitemap  |   Top Stories  |   Taiwan  |   China  |   Business  |   Asia  |   World  |   Sports  |   Life  |   Arts & Leisure  |   Health  |   Editorial  |   Commentary
Travel  |   Movies  |   TV Listings  |   Classifieds  |   Bookstore  |   Getting Around  |   Weather  |   Guide Post  |   Student Post  |   Terms of Use  |   Sitemap
  chinapost search